The diastolic blood pressure in systolic hypertension

Annals of Internal Medicine

Volumn 132, Issue 3, 2000, Pages 233-237

  Smulyan, Harold ^a   Safar, Michel E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NITRATE;

AGE; AORTA; CARDIOVASCULAR RISK; CUFF; DIASTOLIC BLOOD PRESSURE; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYSTOLIC HYPERTENSION;

EID: 0034141868     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-132-3-200002010-00010     Document Type: Review

References (40)

1. Kannel WB, Dawber TR, McGee DL. Perspectives on systolic hypertension. The Framingham Study. Circulation. 1980;61:1179-82.
2. Fineberg MH. Systolic hypertension. Am J Med Sci. 1927;173:835-43.
3. Gubner RS. Systolic hypertension: a pathogenetic entity - significance and therapeutic considerations. Am J Cardiol. 1962;9:773-6.
4. Colandrea MA, Friedman GD, Nichaman MZ, Lynd CN. Systolic hypertension in the elderly. An epidemiologic assessment. Circulation. 1970;41: 239-45.
5. O'Malley K, O'Brien E. Drug therapy: management of hypertension in the elderly. N Engl J Med. 1980;302:1397-401.
6. Prevention of stroke by antihypertensive drug treatrrent in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265: 3255-64.
7. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with solated systolic hypertension The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997;350:757-64.
8. Zweifler AJ, Shahab ST. Pseudohypertension: a new assessment. J Hypertens. 1993;11:1-6.
9. Safar ME, Laurent S, Asmar RE, Safavian A, London GM. Systolic hypertension in patients with arteriosclerosis obliterans of the lower limbs. Angiology. 1987;38:287-95.
10. Vardan S, Mookherjee S, Warner R, Smulyan H. Systolic hypertension. Direct and indirect BP measurements. Arch Intern Med. 1983;143:935-8.
11. Kelly R, Karamanoglu M, Gibbs H, Avolio A, O'Rourke M. Noninvasive carotid pressure wave registration as an indicator of ascending aortic pressure. Journal of Vascular Medicine and Biology. 1989;1:241-7.
12. Karamanoglu M, O'Rourke MF, Avolio AP, Kelly RP. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J. 1993;14:160-7.
13. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL, et al. Estimation of central aortic pressure waveforn by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation. 1997;95:1827-36.
14. Berne RM, Levy MN. The arterial system. In: Cardiovascular Physiology. 7th ed. St Louis: Mosby-Year Book; 1997:137-52.
15. Latham RD, Westerhof N, Sipkema P, Rubal BJ, Reuderink P, Murgo JP. Regional wave travel and reflections along the human aorta: a study with six simultaneous micromanometric pressures. Circulation, 1985;72:1257-69.
16. Nichols WW, O'Rourke MF, Avolio AP, Yaginuma T, Murgo JP, Pepine CJ, et al. Effects of age on ventricular-vascular coupling. Am J Cardiol. 1985; 55:1179-84.
17. Murgo JP, Westerhof N, Giolma JP, Altobelli SA. Aortic input impedance in normal man: relationship to pressure wave forms. Circulation. 1980;62: 105-16.
18. O'Rourke MF. Ageing and arterial function. In: Arterial Function in Health and Disease New York: Churchill Livingstone; 1982:185-95.
19. Safar ME, Asmar R, Benetos A, Levy BI, London GM. Sodium, large arteries, and diuretic compounds in hypertension. Am J Med Sci. 1994; 307(Suppl 1):S3-8
20. Benetos A, Gautier S, Ricard S, Topouchian J, Asmar R, Poirier O, et al. Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation. 1996;94:698-703.
21. Lang RM, Cholley BP, Kocarz C, Marcus RH, Shroff SG. Measurement of regional elastic properties of the human aorta. A new application of transesophageal echocardiography with automated border detection and calibrated subclavian pulse tracings. Circulation. 1994,90:1875-82.
22. Stefanidis C, Stratos C, Vlachopoulos C, Marakas S, Boudoulas H, Kallikazaros I, et al. Pressure-diameter relation of the human aorta. A new method of determination by the application of a special ultrasonic dimension catheter. Circulation. 1995;92:2210-9.
23. Vardan S, Mookherjee S, Warner R, Smulyan H. Systolic hypertension in the elderly. Hemodynamic response to long-term thiazide diuretic therapy and its side effects. JAMA. 1983;250:2807-13.
24. Adamopoulos PN, Chrysanthakopoulis SG, Frohlich ED. Systolic hypertension: nonhomogeneous diseases. Am J Cardiol. 1975;36:697-701.
25. Anderson TW. Re-examination of the Framingham blood-pressure data. Lancet. 1978;2:1139-41.
26. Stewart IM. Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet. 1979;1:861-5.
27. Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potent al harm of lowering high blood pressure. Lancet. 1987;1:581-4.
28. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-74.
29. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827-38.
30. The Systolic Hypertension in the Elderly Program Cooperative Research Group. Implications of the systolic hypertension in the elderly program. Hypertension 1993;21:335-43.
31. Somes GW, Pahor M, Shorr RI, Cushman WC, Appelgate WB. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med. 1999;159:2004-9.
32. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in natients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351:1755-62.
33. Darne B, Girerd X, Safar M, Cambien F, Guise L. Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension. 1989;13:392-400.
34. Fang J, Madhavan S, Cohen H, Alderman MH. Measures of blood pressure and myocardial infarction in treated hypertensive patients. J Hypertens. 1995;13:413-9.
35. Benetos A, Safar M, Rudnichi A, Smulyan H, Richard JL, Ducimetiere P, et al. Pulse pressure. A predictor of long-term cardiovascular mortality in a French male population. Hypertension 1997;30:1410-5.
36. Mitchell GF, Moye LA, Braunwald E, Rouleau JL, Bernstein V, Geltman EM, et al. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE Investigators. Survival and Ventricular Enlargement Circulation. 1997;96:4254-60.
37. Domanski MJ, Mitchell GF, Norman JE, Exner DV, Pitt B, Pfeffer MA. Independent prognost c information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol. 1999;33:951-8.
38. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation. 1999;100:354-60.
39. Nichols WW, Nicolini FA, Pepine CJ. Determinants of isolated systolic hypertension in the elderly. J Hypertension Suppl. 1992;10:S73-7.
40. Duchier J, Iannascoli F, Safar M. Antihypertensive effect of sustained-release isosorbide dinitrate for isolated systolic systemic hypertension in the elderly. Am J Cardiol. 1987;60:99-102.